New drug shows promise in cystic fibrosis

LONDON (Reuters) - A new kind of cystic fibrosis drug, designed to bypass a genetic defect to treat the disease, has produced promising results in mid-stage clinical trials, Israeli researchers said on Thursday. The medicine, known as PTC124, is ...